Actualités
Séminaires

mercredi 15 septembre à 15h, séminaire Mabimprove


Andrew Kruse

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

“VHH antibody fragments as tools to interrogate transmembrane receptor signaling”

"Research in Dr Kruse's lab aims to elucidate the molecular basis of transmembrane signaling through the use of biochemistry, pharmacological studies, and structural biology. He is particularly interested in signaling pathways with connections to human health and disease, including G protein-coupled receptors and other transmembrane receptors. In the long term, he aims to leverage a detailed molecular understanding of these pathways to facilitate the development of new and better therapeutics."


Plus d'informations : https://kruse.hms.harvard.edu/home

Retour à la liste générale

© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés